Cipla P/B Ratio
Cipla (CIPLA) P/B ratio is 3.23 (High), book value per share ₹1931.42 vs Healthcare average P/B of -1.0 — High - Premium to book value, growth expectations or asset-light model. For live price, earnings yield and the full fundamental profile, see Cipla stock price NSE.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
CIPLA P/B Ratio — Valuation Insights & Book Value Analysis
Cipla price-to-book ratio interpretation, valuation status and historical context — current P/B 3.23 (High). View CIPLA 52-week high low for the annual high/low range and current price position.
- Stock appears overvalued with PB of 3.23, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 285.4% above historical average
- Trading at premium to sector average PB of -1.0
Cipla P/B Ratio Historical Trend
CIPLA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with CIPLA fair value to assess whether the stock is under or overvalued.
CIPLA Historical P/B Ratio — Book Value Per Share & Year-End Price
Cipla annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.78 | ₹1931.42 | ₹1511.30 | ₹31,289 | Low |
| 2024 | 0.92 | ₹1654.44 | ₹1529.00 | ₹26,802 | Low |
| 2023 | 0.85 | ₹1472.92 | ₹1246.30 | ₹23,714 | Low |
| 2022 | 0.82 | ₹1311.61 | ₹1075.95 | ₹21,117 | Low |
| 2021 | 0.82 | ₹1154.41 | ₹944.10 | ₹18,586 | Low |
CIPLA vs Healthcare Peers — P/B Ratio Comparison
Cipla P/B 3.23 vs Healthcare average -1.0, median 0.62 — range -36.63–1.05.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -36.63 | ₹28 | Low |
| Sun Pharma Advanced Rese… | SPARC | -13.83 | ₹4,744 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.35 | ₹76 | Low |
| Parmax Pharma | PARMAX | -2.09 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |